Skip to main navigation Skip to search Skip to main content

Craniofacial fibrous dysplasia: An update

  • Yu Ray Chen*
  • , Cheng Nen Chang
  • , Ying Chien Tan
  • *Corresponding author for this work
  • Chang Gung Memorial Hospital
  • Chang Gung University
  • Singapore General Hospital

Research output: Contribution to journalReview articlepeer-review

48 Scopus citations

Abstract

Fibrous dysplasia was first described by Lichtenstein in 1938 as a disorder characterized by progressive replacement of normal bone elements by fibrous tissue. It is a bone tumor that, although benign, has the potential to cause significant cosmetic and functional disturbance, particularly in the craniofacial skeleton. Its management poses significant challenges to the surgeon. Its compression of the optic nerve with resulting visual impairment is especially alarming. Over the years, we have gained a better understanding of its etiology, clinical behavior, and both surgical and non-surgical treatments. Its characteristics, under various imaging modalities, have been thoroughly described in recent years. These developments have taken place with the goal of optimizing treatment of those who suffer from this disease. However, the role of prophylactic optic nerve decompression in cases of optic canal involvement has recently been challenged: the results of a few recent studies have raised questions regarding its role. Further studies would be required to assess its value.

Original languageEnglish
Pages (from-to)543-549
Number of pages7
JournalChang Gung Medical Journal
Volume29
Issue number6
StatePublished - 11 2006

Keywords

  • Bisphosphonate
  • Craniofacial fibrous dysplasia
  • Decompression
  • Optic canal
  • Optic nerve
  • Pamidronate

Fingerprint

Dive into the research topics of 'Craniofacial fibrous dysplasia: An update'. Together they form a unique fingerprint.

Cite this